Marcelo Bigal
Fortune : 460 968 $ au 31/08/2026
Fortune : 460 968 $ au 31/08/2026
Marcelo Bigal currently works at Ventus Therapeutics U.S., Inc., as President, Chief Executive Officer & Director, Ventus Therapeutics, Inc., as President, Chief Executive Officer & Director from 2019, Pacira Biosciences, Inc., as Independent Director from 2023, and Santa Ana Bio, Inc., as Director.
Dr. Bigal also formerly worked at CODA Biotherapeutics, Inc., as Director from 2019 to 2022, Teva Pharmaceutical Industries Ltd., as Chief Medical Officer & Head-Specialty Clinical from 2017 to 2018, Labrys Biologics, Inc., as Chief Medical Officer, and Versant Venture Management LLC, as Venture Partner.
Dr. Bigal received his doctorate degree from Faculdade de Direito da Universidade de São Paulo.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/06/2026 | 17 798 ( 0,05% ) | 460 968 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 10/10/2023 |
Ventus Therapeutics, Inc.
Ventus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Directeur Général | 01/05/2019 |
Ventus Therapeutics U.S., Inc.
Ventus Therapeutics U.S., Inc. Medical DistributorsDistribution Services Wholesales drugs | Directeur Général | - |
Santa Ana Bio, Inc.
Santa Ana Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on precision immunology for autoimmune diseases | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Private Equity Investor | 01/09/2023 |
CODA Biotherapeutics, Inc.
CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology Develops chemo genetic neuromodulation platform for the treatment of severe neurological disorders | Directeur/Membre du Conseil | 01/12/2022 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Directeur Technique/Scientifique/R&D | 01/03/2018 |
Labrys Biologics, Inc.
Labrys Biologics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Labrys Biologics, Inc.
Labrys Biologics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Pacira Biosciences, Inc.
Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
Faculdade de Direito da Universidade de São Paulo
Faculdade de Direito da Universidade de São Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CODA Biotherapeutics, Inc.
CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology Develops chemo genetic neuromodulation platform for the treatment of severe neurological disorders | Health Technology |
Ventus Therapeutics, Inc.
Ventus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Health Technology |
Ventus Therapeutics U.S., Inc.
Ventus Therapeutics U.S., Inc. Medical DistributorsDistribution Services Wholesales drugs | Distribution Services |
Santa Ana Bio, Inc.
Santa Ana Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on precision immunology for autoimmune diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national